Astral shares will be on investors’ radar as the company, on Thursday, June 11, said its subsidiary Astral Chemie has acquired a 60% stake in Differentiated and Sustainable Solutions LLP (DSS) for ₹39.11 crore.
DSS has been a pioneer in the development, manufacturing, and marketing of high-end specialty products and advanced materials in the Indian chemical industry. The firm is the only entity in India to possess a technology to produce a wide range of polyamines and very unique bismaleimides and benzoxazines (specialty chemicals).
The products of DSS are approved by most of the major customers in India. Globally, these products are manufactured by very few players, and there remains significant opportunity to export to the USA, EU, Japan, and other major economies.
Along with the products, DSS is also engaged in the design, development, and scale-up of specialty chemicals and high-performance advanced materials, with many Indian and overseas clients. The firm also holds and applies for the intellectual property rights for many industrially important chemical processes and products.
Astral in a statement said that while it offers a strong global platform and ecosystem to leverage technologies and complementary product portfolios for accelerating growth, DSS brings a significant strategic fit to its backward integration in key raw materials.
It added that the partnership would enable deeper insights into chemistries and technologies to strengthen its adhesives, construction, and coatings portfolios, while also facilitating entry into electronics, aerospace, renewable energy, and infrastructure segments.
Here’s what management said
“While strengthening our core chemicals platform, this investment expands Astral’s capabilities in specialty chemicals and high-value B2B markets, reflecting our continued focus on building technology-led businesses that complement our leadership in building materials, renewable energy, and infrastructure solutions,” said Saumya Engineer, CEO-Adhesives and Paints Business of Astral Limited.
The engineer further said that the acquisition is aligned with Astral’s long-term strategy of investing in technology-led capabilities to build enduring competitive advantages.
He added that the inclusion of advanced specialty chemicals and proprietary expertise would strengthen the company’s technology platform, deepen backward integration across critical chemistries, and enhance its R&D capabilities, enabling greater innovation across adhesives, paints, and construction chemicals while reinforcing value chain resilience.
Astral share price
On Thursday, Astral shares settled at ₹1,490.20 apiece on the National Stock Exchange, falling 0.75%.
Over a month’s time, the stock has fallen 5%, while it has gained 6% in the last six months. From the beginning of the year, Astral shares have climbed over 4%.
Shares of the company had touched their one-year high of ₹1,768.70 apiece on March 11, 2026, while their 52-week low of ₹1,263.70 was hit on August 12, 2025.
Astral Q4 earnings
The company reported a 20% jump in consolidated net profit at ₹213 crore for the fourth quarter of the financial year (Q4 FY26) as compared to ₹179 crore in the same period last year.
Its revenue from operations also grew 24% year-on-year (YoY) to ₹2,089 crore in the January-March period from ₹1,681 crore in the year-ago period.
Astral reported strong operational performance as its earnings before interest, taxes, depreciation, and amortization (EBITDA) increased 25.5% annually to ₹383 crore as against ₹305 crore in Q4 FY25.
The operating profit margin in the reporting quarter expanded marginally to 18.34%, in contrast to 18.14% on a yearly basis.
According to NSE data, the company has a market capitalization of ₹40,128.27 crore.